The manufacturer of semaglutide is securing future treatments as key patents begin to expire globally.
Live Poll
Do you trust that large pharmaceutical companies can innovate effectively as their major drug patents expire?
October 7, 2026
Nova Biomedical Issued Correction for Glucose MetersA software error on specific hospital monitors led to a global device correction for patients and medical staff.
October 6, 2026
Researchers Proposed New Dressing for Diabetic WoundsA theoretical wound dressing design aims to treat complex diabetic injuries using a multi-component, pH-responsive system.
October 6, 2026
Anjac Health & Beauty Launched GLP-1 Support PlatformThe company has introduced a new product range to support people using GLP-1 treatments for diabetes or weight management.
October 5, 2026
Orforglipron Proved Safe for Diabetes Heart HealthThe oral medication demonstrated cardiovascular safety and better weight control than insulin glargine in a trial.
October 5, 2026
Novo Nordisk Has Targeted Oral Wegovy Production ScaleThe manufacturer plans to expand partnerships to meet a projected tenfold increase in demand for oral weight-loss treatments by 2030.
October 5, 2026
DMX-200 Kidney Disease Study Reached MilestonePatients with focal segmental glomerulosclerosis have now completed two years of long-term DMX-200 treatment.
October 2, 2026
Chatbot Model Reduced Diabetes Care DropoutsAutomated reminders helped patients with diabetes and hypertension stay connected to follow-up care.
October 2, 2026
STEAP2 Gene Link Linked to Insulin SecretionResearchers have identified a genetic factor that influences how the body secretes insulin in mouse models.
October 1, 2026
Rotavirus Vaccine Linked to No Type 1 Diabetes RiskNew research shows the vaccine does not increase the risk of type 1 diabetes in children.
October 1, 2026
New 5.5 ml Syringe System Facilitates Large-Volume DosesA new passive safety device and syringe combination may help patients manage large-volume biologic injections at home.
